700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Journal of Lung Diseases & Treatment, a broad-based journal was founded on two key tenets: To publish the most exciting researches with respect to the subjects of Lung Diseases & its Treatment. Secondly, to provide a rapid turn-around time possible for reviewing and publishing and to disseminate the articles freely for research, teaching and reference purposes.
» In today's wired world information is available at the click of the button, curtsey the Internet. Journal of Lung Diseases & Treatment-Open Access gives a worldwide audience larger than that of any subscription-based journal in OMICS field, no matter how prestigious or popular, and probably increases the visibility and impact of published work. Journal of Lung Diseases & Treatment-Open Access gives barrier-free access to the literature for research. It increases convenience, reach, and retrieval power. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. Journal of Lung Diseases & Treatment-Open Access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content.
» OMICS International is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in OMICS scientific and technical disciplines.
» All published articles will be assigned DOI provided by CrossRef. Journal of Lung Diseases & Treatment will keep upto date with latest advances in the field and papers published in Journal of Lung Diseases & Treatment will reach the readers directly by email for free of cost.
» Distributed widely through the Internet.
» Archived online in the transactions of the OMICS International, which provides the international scientific community with immediate and permanent access to individual papers.
» Journal of Lung Diseases & Treatment accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in OMICS field.
» Open Access is a publication model that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Journal of Lung Diseases & Treatment strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Lung Diseases & Treatment are freely accessible to everyone immediately after publication.
» All works published by OMICS International are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Lung Diseases & Treatment supports the Bethesda Statement on Open Access Publishing.
Definition of Open Access Publication
» An Open Access Publication is one that meets the following two conditions:
• The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
• A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
» As a member of Publisher International linking Association, PILA, Journal of Lung Diseases & Treatment (of OMICS International) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.
» Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.